Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Derivation and Characterization of Mesenchymal Stem Cells from iPS Cells
1Molecular and Cellular Medicine Department, Institute for Regenerative Medicine, College of Medicine, Texas A&M University Health Science Center, College Station, TX, USA.
Abstract:
Mesenchymal stem/stromal cells (MSCs) show excellent therapeutic potentials in many preclinical studies and clinical trials. However, the clinical application of conventional tissue-derived MSCs faces challenges of limited scalability and high donor variations. To address these challenges, we established a protocol for deriving and characterizing MSCs from human induced pluripotent stem cells (iPSCs) with a theoretically limitless expandability. The iPSC-MSCs show biological properties comparable to or better than early passage bone marrow MSCs and can be scaled up to huge amounts with uniform properties.
Related Concept Videos
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
iPS Cell Differentiation
EPS and iPS Cells in Disease Research

